|
|
|
|
|
Yuko Terada, Kenjiro Tanaka, Minami Matsuyama, Masaya Fujitani, Masatoshi Shibuya, Yoshihiko Yamamoto, Ryuji Kato and Keisuke Ito
Because transient receptor potential ankyrin 1 (TRPA1) is involved in various physiological functions, TRPA1-targeting drugs have been energetically developed. Although TRPA1 is considered a multimodal receptor, the structural diversity of TRPA1 agonists...
ver más
|
|
|
|
|
|
|
|
|
|
|
Yasushi Sekine, Keisuke Tanaka, Masahiko Matsukata and Eiichi Kikuchi
Pág. 613 - 616
|
|
|
|
|
|
|
|
|
|
|
Keisuke Shinozaki, Akio Hoshino, Yoshitaka Ishisaki, Umeyo Morita, Takaya Ohashi, Tatehiro Mihara, Kazuhisa Mitsuda, Keiichi Tanaka, Yasuyuki Yagi, Haruhisa Koguchi, Yoichi Hirano, and Hajime Sakakita
|
|
|
|
|
|
|
|
|
|
|
Junichi Tanaka,Keisuke Ono,Shigenari Hayashi,Kenichi Ohsasa and Toshio Narita
Pág. 80 - 85
|
|
|
|
|
|